HMGA1 and uterine cervix neoplasm: Several other studies have reported miR-214 to suppress cervical tumour growth and metastasis through targeting and downregulating high mobility group AT-hook 1 (HMGA1) [68], Plexin-B1 [72], Bcl2l2 [62], Ezh2 [63], and forkhead box protein M1 (FOXM1) [66].